Status:
UNKNOWN
The RIsk Stratification in COVID-19 Patients in the ICU Registry
Lead Sponsor:
University of Zurich
Conditions:
Critical Illness
ARDS
Eligibility:
All Genders
Brief Summary
The Risk stratification in COVID-19 patients in the ICU (RISC-19-ICU) registry was founded during the emerging SARS-CoV-2 pandemic. COVID-19 is a novel disease caused by infection with the SARS-CoV-2 ...
Eligibility Criteria
Inclusion
- Admission to an intensive care unit in a collaborating center due to COVID-19
Exclusion
- Missing ethical approval
Key Trial Info
Start Date :
March 13 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT04357275
Start Date
March 13 2020
End Date
December 1 2025
Last Update
December 22 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of Zurich
Zurich, Switzerland, 8091